US warns of cyber attacks on medical devices

A man uses a robot to practice surgery in Melle on April 15, 2013. US authorities on Thursday warned makers of medical devices and hospital networks to step up efforts to guard against potential cyber attacks.

US authorities on Thursday warned makers of medical devices and hospital networks to step up efforts to guard against potential cyber attacks.

The said implanted devices, which could include pacemakers or defibrillators, could be connected to networks that are vulnerable to hackers.

An FDA warning notice was sent to medical device manufacturers, hospitals, medical device user facilities, health care technical staff and .

It said the agency has recently "become aware of cybersecurity vulnerabilities and incidents that could directly impact medical devices or hospital network operations."

"The FDA is recommending that and take steps to assure that appropriate safeguards are in place to reduce the risk of failure due to cyberattack," the warning said.

These devices or systems could be compromised "by the introduction of malware into the medical equipment or unauthorized access to configuration settings in medical devices and hospital networks," the FDA said.

"This may sound like it is out of a science fiction movie, but the threat is conceivably a serious one," said Jon Ogg at 24/7 Wall Street.

"Can you imagine a device being retooled maliciously, like an inserted pacemaker/defibrillator? Or imagine if a system was maliciously recalibrated in even a slight manner for surgeries.

"The list of threats is endless."

The FDA said it was "not aware of any patient injuries or deaths associated with these incidents" nor does it have any specific information on targeted devices.

The FDA said it had been working with other federal agencies as well as manufacturers, which it said are "responsible for remaining vigilant about identifying risks and hazards associated with their medical devices."

Among the measures that should be taken, the FDA said, are limiting unauthorized device access, "particularly for those devices that are life-sustaining or could be directly connected to hospital networks."

add to favorites email to friend print save as pdf

Related Stories

Security experts sound medical device malware alarm

Oct 19, 2012

(Phys.org)—Speakers at a government gathering revealed more reasons for nervous patients to get out their worry beads over future hospital stays. Besides staph infections, wrong-side surgeries and inaccurate ...

Judges side with FDA in rejecting stem cell device

Mar 22, 2013

(AP)—A federal appeals court is siding with the Food and Drug Administration in a case brought by medical device maker Cytori, ruling that the agency was correct to reject fast-track approval for two company devices used ...

FDA proposes new rules for heart defibrillators

Mar 22, 2013

(AP)—The Food and Drug Administration will require makers of heart-zapping defibrillators to submit more data on their safety and effectiveness following years of recalls of the emergency devices.

FDA pledges support for med tech initiative

Dec 03, 2012

(AP)—The Food and Drug Administration says it will collaborate with medical device manufacturers on a public-private partnership designed to speed up the development of new medical technology.

FDA aims to accelerate medical device reviews

Feb 08, 2011

(AP) -- Federal health officials have proposed a plan that would speed up the approval of innovative medical devices that hold the potential to dramatically improve patients' lives.

Recommended for you

Determine patient preferences by means of conjoint analysis

3 hours ago

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

User comments